Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma ; volume:13 ; number:1 ; day:20 ; month:8 ; year:2014 ; pages:1-15 ; date:12.2014
Molecular cancer ; 13, Heft 1 (20.8.2014), 1-15, 12.2014
- Urheber
-
Wong, Deborah JL
- Beteiligte Personen und Organisationen
-
Robert, Lidia
Atefi, Mohammad S.
Lassen, Amanda
Avarappatt, Geetha
Cerniglia, Michael
Avramis, Earl
Tsoi, Jennifer
Foulad, David
Graeber, Thomas G.
Comin-Anduix, Begonya
Samatar, Ahmed
Lo, Roger S.
Ribas, Antoni
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-13-194
- URN
-
urn:nbn:de:1111-201609063777
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wong, Deborah JL
- Robert, Lidia
- Atefi, Mohammad S.
- Lassen, Amanda
- Avarappatt, Geetha
- Cerniglia, Michael
- Avramis, Earl
- Tsoi, Jennifer
- Foulad, David
- Graeber, Thomas G.
- Comin-Anduix, Begonya
- Samatar, Ahmed
- Lo, Roger S.
- Ribas, Antoni
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
Cognitive phenotyping of wildtype and mutant mouse lines
Variations of BRAF mutant allele percentage in melanomas
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
Cognitive phenotyping of wildtype and mutant mouse lines
Variations of BRAF mutant allele percentage in melanomas
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy
Optimizing the treatment of BRAF mutant melanoma
Novel combination therapies for BRAF-mutant melanoma
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
Cognitive phenotyping of wildtype and mutant mouse lines